(19)
(11) EP 1 441 725 A1

(12)

(43) Date of publication:
04.08.2004 Bulletin 2004/32

(21) Application number: 02801954.5

(22) Date of filing: 24.10.2002
(51) International Patent Classification (IPC)7A61K 31/4184, C07D 403/04, C07D 403/14, C07D 413/04, C07D 413/14, C07D 405/14, C07D 409/14, C07D 491/04, C07D 401/14, C07D 487/04, C07D 471/04, A61P 35/00
// (C07D491/04, 319:00), C07D235:00
(86) International application number:
PCT/GB2002/004763
(87) International publication number:
WO 2003/035065 (01.05.2003 Gazette 2003/18)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 26.10.2001 FR 0113868
22.03.2002 GB 0206893
22.03.2002 GB 0206895
11.07.2002 US 395151 P
11.07.2002 US 395060 P

(71) Applicant: Aventis Pharmaceuticals Inc.
Bridgewater, New Jersey 08807 (US)

(72) Inventors:
  • EDWARDS, Michael, Louis
    Morristown, NJ 07960 (US)
  • COX, Paul, Joseph
    Millington, NJ 07964 (US)
  • AMENDOLA, Shelley
    Bedminster, NJ 07921 (US)
  • DEPRETS, Stephanie, Daniele
    F-75015 Paris (FR)
  • GILLESPY, Timothy, Alan
    Hillsboro, NJ 08844 (US)
  • EDLIN, Christopher, David
    HitchinHerts SG5 1QD (GB)
  • MORLEY, Andrew, David
    MacclesfieldCheshire SK10 3QW (GB)
  • GARDNER, Charles, J.
    Royersford, NJ 10469 (US)
  • PEDGRIFT, Brian
    Morristown, NJ 07960 (US)
  • BOUCHARD, HervĂ©
    F-94320 Thiais (FR)
  • BABIN, Didier
    F-78180 Montigny (FR)
  • GAUZY, Laurence
    F-75005 Paris (FR)
  • LE BRUN, Alain
    F-91270 Vigneux (FR)
  • MAJID, Tahir, Nedeem
    Hoboken, NJ 07030 (US)
  • READER, John, C.
    LintonCambridge, CB1 6JS (GB)
  • PAYNE, Lloyd, J.
    ElyCambridge CB7 5EZ (GB)
  • KHAN, Nawaz, M.
    HardwickCambridge CB3 7QN (GB)
  • CHERRY, Michael
    NewmarketSuffolk CB8 0JS (GB)

(74) Representative: Rousseau, Pierrick Edouard et al
Aventis Pharma S.A.Direction des Brevets,Tri LEO/14420, avenue Raymond Aron
92165 Antony Cedex
92165 Antony Cedex (FR)

   


(54) BENZIMIDAZOLES AND ANALOGUES AND THEIR USE AS PROTEIN KINASES INHIBITORS